Table 1

Expression of claudin-6, occludin and MMP-2and clinicopathological characteristics in breast carcinoma patients
Variables No. Claudin-6 Occludin MMP-2
Positive Negative p Positive Negative p Positive Negative p
Patient Age
 20-40 9 6 3 0.696* 4 5 0.846* 6 3 0.900*
 41-60 20 14 6 11 9 15 5
 61-80 7 5 2 4 3 5 2
Histology
 Ovarian papillary serous carcinoma 36 25 11 0.007 19 17 0.108* 26 10 0.001
 Ovarian serous adenomas 26 9 17 19 7 8 18
Pathological Grade
 I 14 9 5 0.696* 8 6 0.918* 9 5 0.6820*
 II 12 8 4 6 6 9 3
 III 10 8 2 5 5 8 2
Clinical Stage
 I-II 20 13 7 0.777* 10 10 0.709* 11 9 0.028
 III-IV 16 12 4 9 7 15 1
Metastasis
 Positive 13 11 2 0.267* 7 6 0.923* 12 1 0.037
 Negative 23 14 9 12 11 14 9

chi-square test.

*No statistical significance.

Wang et al.

Wang et al. Diagnostic Pathology 2013 8:190   doi:10.1186/1746-1596-8-190

Open Data